TD Cowen raises Revolution Medicines target price to $270 from $250
RVMD•TD Cowen raised its target price for Revolution Medicines to $270 from $250.
Related News
United Therapeutics: BTIG raises target price to $768 from $728
UTHR•
German industrial orders rise slower than expected
SPY•
Pharma group Egetis soars after $547 million takeover offer from ANI
ANIP•
ATRenew publishes update to financial calendar
RERE•
ISG hosts AI Impact Summit focused on measurable business returns
III•